The protein kinase C-β inhibitor, ruboxistaurin, for the treatment of diabetic microvascular complications
Author:
- 25 November 2005
- journal article
- research article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 14 (12) , 1547-1559
Abstract
The potential for addressing the underlying biological abnormalities in diabetes has eluded most investigators because of the complex mechanisms underlying the effects of diabetes on the pathogenesis of the complications. Although macrovascular complications, such as myocardial infarction, stroke and gangrene, are only partially attributable to hyperglycaemia and its attendant effects, the microvascular complications including retinopathy, nephropathy and neuropathy are directly related to the degree of hyperglycaemia. In controlled trials, a 22 – 34% reduction in one of these side effects was achieved for every 1% reduction in glycosylated haemoglobin. Theoretically, it should be feasible to eliminate these complications in a perfect world. However, achieving euglycaemia is nearly impossible and there is increasing data to suggest that it may be an elusive target with ever lower levels being implicated in the pathogenesis of microvascular disease and there is a price to be paid of hypoglycaemia if furthe...Keywords
This publication has 63 references indexed in Scilit:
- Protein Kinase Cβ Inhibition Attenuates Osteopontin Expression, Macrophage Recruitment, and Tubulointerstitial Injury in Advanced Experimental Diabetic NephropathyJournal of the American Society of Nephrology, 2005
- Inactivation of 14-3-3 Protein Exacerbates Cardiac Hypertrophy and Fibrosis through Enhanced Expression of Protein Kinase C .BETA.2 in Experimental DiabetesBiological and Pharmaceutical Bulletin, 2005
- Possible role of the protein kinase C/CPI‐17 pathway in the augmented contraction of human myometrium after gestationBritish Journal of Pharmacology, 2003
- Role of PKC and TGF-β Receptor in Glucose-Induced Proliferation of Smooth Muscle CellsBiochemical and Biophysical Research Communications, 2001
- Vascular Dysfunction Induced by AGE is Mediated by VEGF via Mechanisms Involving Reactive Oxygen Species, Guanylate Cyclase, and Protein Kinase CMicrocirculation, 2001
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats.Journal of Clinical Investigation, 1997
- Design of Controlled Clinical Trials for Diabetic PolyneuropathySeminars in Neurology, 1996
- Basement membrane reduplication and pericyte degeneration precede development of diabetic polyneuropathy and are associated with its severityAnnals of Neurology, 1995
- Vibratory and Cooling Detection Thresholds Compared With Other Tests in Diagnosing and Staging Diabetic NeuropathyDiabetes Care, 1987